Quest Diagnostics Incorporated (DGX)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 137.55 |
| Open | 137.42 |
| Bid | 134.14 x 800 |
| Ask | 135.86 x 1100 |
| Day's range | 135.35 - 137.42 |
| 52-week range | 119.59 - 145.58 |
| Volume | |
| Avg. volume | 1,035,668 |
| Market cap | 15.146B |
| Beta (5Y monthly) | 0.89 |
| PE ratio (TTM) | 18.35 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 3.00 (2.18%) |
| Ex-dividend date | 05 Apr 2024 |
| 1y target est | N/A |
- Zacks
Reasons to Retain Quest Diagnostics (DGX) Stock for Now
Investors are optimistic about Quest Diagnostics (DGX) on strong legacy business growth.
- Zacks
Quest Diagnostics (DGX) Inks Deal to Acquire PathAI Diagnostics
Quest Diagnostics' (DGX) latest transaction combines its oncology expertise and scale with PathAI's AI and digital pathology innovations.
- Simply Wall St.
Quest Diagnostics Incorporated Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
A week ago, Quest Diagnostics Incorporated ( NYSE:DGX ) came out with a strong set of first-quarter numbers that could...
© 2024 Yahoo. All rights reserved.